Next-Generation Sequencing for Deep Genomic and Transcriptomic Insight

From gene discovery and mutation analysis to biomarker identification, next-generation sequencing (NGS) turns a strain, sample, or clinical specimen into a complete genomic or transcriptomic picture. Alongside Sanger sequencing for targeted, high-accuracy reads and DNA fragment analysis for STR profiling, NGS is the workhorse technology behind modern genomic characterization.

This service is performed by Hy Laboratories (HyLabs), Alagene's parent company and the largest, most experienced industrial genomics and sequencing service lab in the region. As a fully accredited lab, HyLabs runs both Sanger and NGS platforms alongside advanced bioinformatics analysis, delivering research-grade and regulatory-grade results with fast turnaround times.

Working through HyLabs is one of the real advantages of being part of the Alagene family: customers get the best of both worlds — Alagene's strain engineering expertise alongside HyLabs' vast, accredited sequencing infrastructure. Together, this turns genomic and transcriptomic sequencing into part of a genuine end-to-end solution, from strain design and screening through production and the deep sequence-level verification needed to support it.

Whether the goal is confirming a genetic modification, profiling gene expression, or generating the sequencing data behind a regulatory submission, this combined infrastructure means samples don't have to leave the Alagene ecosystem to get there.